Probing the Intracellular Delivery of Nanoparticles into Hard-to-Transfect Cells

Area of Science:

• Biotechnology
• Cell Biology
• Nanomedicine

Background:

• Hard-to-transfect cells pose significant challenges for intracellular delivery of exogenous materials.
• The specific transport mechanisms in these cells remain poorly understood, hindering effective delivery strategies.

Purpose of the Study:

• To investigate and quantitatively analyze nanoparticle transport in bone marrow-derived mesenchymal stem cells (BMSCs), a type of hard-to-transfect cell.
• To elucidate the differences in nanoparticle transport pathways and kinetics between BMSCs and standard cell lines like HeLa cells.
• To develop a predictive model for nanoparticle delivery in BMSCs.

Main Methods:

• Utilized single-particle motion analysis, including pair-correlation function and single-particle tracking, on Tat peptide-conjugated quantum dots (QDs-Tat).
• Conducted complementary cell biology studies to examine cellular uptake, vesicular transport, and exocytosis mechanisms.
• Employed a reaction-diffusion-advection model to integrate transport steps and predict delivery efficiency.

Main Results:

• Demonstrated significantly more difficult vesicle escape and cytoplasmic diffusion of QDs-Tat in BMSCs compared to HeLa cells.
• Identified distinct biological pathways utilized by BMSCs for cellular uptake, vesicular transport, and exocytosis of nanoparticles.
• Quantified mechanistic differences in nanoparticle transport at each stage within BMSCs.

Conclusions:

• BMSCs exhibit unique and challenging nanoparticle transport behaviors compared to standard cell lines.
• The developed understanding and mathematical model can guide the design of targeted nanoparticle delivery systems for BMSCs.
• This research provides a framework for investigating and optimizing delivery in various hard-to-transfect cell types.